Sign up for the QMED & MD+DI Daily newsletter.
Boston Scientific to Investors: Don't Worry
Boston Scientific told its investors that the 40% decline in its stock during the first ten days of the month isn't indicative of the financial performance of the company. It began
October 15, 2008
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
According to the Pioneer Press, the bankruptcy of Lehman Brothers resulted in an inability of Boston Scientific's cofounders to access assets.In other news, Boston Scientific reported that its share of the drug-eluting stent market reached 45% for the third quarter.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)